Japanese Research Finds Tamiflu And Relenza Early Administration Reduces Fever Symptoms
This article was originally published in PharmAsia News
Executive Summary
A research study released by Japan's National Institute of Infectious Disease found that patients affected with new strains of H1N1 flu virus who received earlier administration of flu drugs such as Tamiflu (oseltamivir) or Relenza(zanamivir) had shorter periods of fever symptoms. Conducted in Osaka with 171 patients, the research found that on average patients treated within 24 hours of infection had fever systems that lasted 1.9 days; those treated after one day had a fever for 2.5 days and those who were treated between two to five days had a fever for 3-4 days. (Click here for more - Japanese language
You may also be interested in...
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.
ImmunityBio Will Aim Anktiva At Large Share Of Bladder Cancer Market
Execs Richard Adcock and Patrick Soon-Shiong told Scrip the company sees an addressable US population of about 20,000 and is aiming for ease of physician adoption.